China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on a risk prediction model for IMNM with positive anti-HMGCR antibodies combined with lung cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136306
Registration Time: 2026/11/09
Type: Observational study
Primary Sponsor: Binhai New Area Hospital of TCM.Tianjin
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339691
Published by HT Digital Content Services with permission from Health Daily Digest....